Navigation Links
Inverness Medical Innovations to Present at 2008 UBS Global Healthcare Services Conference on February 13, 2008
Date:2/6/2008

WALTHAM, Mass., Feb. 6 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (Amex: IMA), a leading manufacturer and marketer of rapid diagnostic products for the consumer and professional markets, announced today that it will attend the upcoming 2008 UBS Global Healthcare Services Conference being held February 11 through 13, 2008 at the Grand Hotel Hyatt in New York City. Ron Zwanziger, Chief Executive Officer, and Jon Russell, Vice President, Finance, will attend. Their presentation is scheduled for Wednesday, February 13, 2008 at 8:30 a.m., and will be made available to the public through a webcast accessible through the company's website at http://www.invmed.com/investors.cfm and the UBS Investment Bank website at http://www.ibb.ubs.com. A replay of the webcast will be available via the links above for approximately one month from the date of the webcast. During their presentation Mr. Zwanziger and Mr. Russell may discuss and answer questions concerning business and financial developments and trends. Their responses to questions, as well as other matters discussed during the webcast, may contain or constitute information that has not been disclosed previously.

The investor presentation used at the conference will be made available on the Company's website at http://www.invmed.com/presentations.cfm.

By developing new capabilities in near-patient diagnosis, monitoring and health management, Inverness Medical Innovations enables individuals to take charge of improving their health and quality of life. A global leader in rapid point-of-care diagnostics, Inverness' products, as well as its new product development efforts, focus on infectious disease, cardiology, oncology, drugs of abuse and women's health. Inverness is headquartered in Waltham, Massachusetts.


'/>"/>
SOURCE Inverness Medical Innovations
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Inverness Medical Innovations Enters Into a Definitive Agreement to Acquire Matria Healthcare, Inc.
2. Inverness Medical Innovations to Acquire Redwood Toxicology Laboratory
3. Inverness Medical Innovations to Participate at 2007 RBC Healthcare Conference on December 12, 2007
4. Inverness Medical Innovations Announces Closing of Public Offering
5. Inverness Medical Innovations Acquires Alere Medical
6. Inverness Medical Innovations Acquires Bio-Stat Healthcare Group
7. Inverness Completes Acquisition of Cholestech
8. Dr. Inder Verma named recipient of 2008 Vilcek Prize in biomedical science
9. MarketResearch.com Distributes Key Findings on Global Specialty Medical Beds and Therapeutic Surfaces Market
10. Margaret Dimond Named President and CEO of McLaren Medical Management Inc.
11. Rising Medical Solutions, Inc. Ranks Fifth on the Private Company Index (PCI) Top Growth Companies List
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2017)... Centennial, CO (PRWEB) , ... August 20, 2017 , ... ... in the same household? If so, you may be interested in participating in ... The purpose of this research is to understand more about the relational aspects of ...
(Date:8/19/2017)... York, New York (PRWEB) , ... August 19, ... ... Street Health has announced that it is the first organization with pending recognition ... CDC’s National Diabetes Prevention Program (“DPP”) via group telehealth classes and live video ...
(Date:8/19/2017)... ... August 19, 2017 , ... Physician Partners ... Orlando location as an interventional pain management physician. He brings a wealth of ... of migraine headaches, and significant experience in spinal cord stimulation for chronic pain. ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... specialized asset-light logistics provider of complex transport solutions for mission-critical and non-discretionary ... Unitrans International Corporation, a division of Roadrunner Transportation Systems, Inc. (NYSE: RRTS). ...
(Date:8/18/2017)... ... ... The Dawn Johnson Insurance Group, a Missouri-based insurance and financial planning firm ... for efforts to educate the local population on cancer realities while attracting donations to ... , Each day in America, roughly 4,600 new cases of cancer are diagnosed and ...
Breaking Medicine News(10 mins):
(Date:7/28/2017)... July 28, 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") ... third quarter ended June 30, 2017, and updated its ... For the fiscal third quarter, Hill-Rom ... $0.68 per diluted share in the prior-year period. These ... $0.39 per diluted share primarily related to the non-cash ...
(Date:7/27/2017)... July 27, 2017  West Pharmaceutical Services, Inc. (NYSE: ... for the second-quarter 2017 and updated financial guidance for ... Second-Quarter 2017 Highlights Reported net sales ... the prior-year quarter. Net sales at constant currency (organic) ... EPS was $0.51, compared to $0.60 in the prior-year ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals ... of our clinical trial evaluating Altemia TM , an ... (SCA) and Sickle Cell Disease (SCD). The SCOT Trial, ... the efficacy and safety of Altemia TM in ... conducted under US IND 125274. ...
Breaking Medicine Technology: